Between 2025 and the first quarter of 2026, 112,000 fewer commercially insured members used a GLP-1 drug for weight loss. That 52% decline contributed to decreased 2026 annualized spending of $662 million.
This Peabody Award–winning podcast dives into the cynicism that hangs over the topic of American infrastructure. No project embodies that cynicism quite like ‘The Big Dig.’